Medscape, LLC requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

All relevant financial relationships for anyone with the ability to control the content of this educational activity are listed below and have been mitigated. Others involved in the planning of this activity have no relevant financial relationships.

Faculty

Geneviève Baujat, MD, MSc

Clinical Geneticist Consultant
Imagine Institute of Necker-Enfants Malades Hospital
Paris, France

Disclosures

Geneviève Baujat, MD, MSc, has the following relevant financial relationships:
Speaker or member of speakers bureau for: Ipsen
Research funding from: Incyte; Ipsen

Patricia L. R. Delai, MD

Professor of Rare Diseases
Dental and Medical School São Leopoldo Mandic
Medical Advisor, Brazilian FOP Association
Member of the International Clinical Council on FOP
São Paulo, Brazil

Disclosures

Patricia L. R. Delai, MD, has the following relevant financial relationships:
Speaker or member of speakers bureau for: Ipsen
Research funding from: Ipsen

Editors

Iwona Misiuta, PhD, MHA

Medical Education Director, Medscape, LLC

Disclosures

Iwona Misiuta, PhD, MHA, has no relevant financial relationships.

Kalanethee Paul-Pletzer, PhD

Medical Education Director, Medscape, LLC

Disclosures

Kalanethee Paul-Pletzer, PhD, has no relevant financial relationships.

Compliance Reviewer

Susan L. Smith, MN, PhD

Associate Director, Accreditation and Compliance, Medscape, LLC

Disclosures

Susan L. Smith, MN, PhD, has no relevant financial relationships.

Peer Reviewer

This activity has been peer reviewed and the reviewer has the following relevant relationships:
Consultant or advisor for: ALife Health
Stock options for: ALife Health

CME

Fibrodysplasia Ossificans Progressiva: Expert Guidance on Diagnosis and Management

Authors: Geneviève Baujat, MD, MSc; Patricia L. R. Delai, MD
CME Released: 1/4/2023
Valid for credit through: 1/4/2024, 11:59 PM EST

Start Activity

Credits Available

Physicians - maximum of 0.75 AMA PRA Category 1 Credit(s)™

You Are Eligible For
- Letter of Completion

Target Audience and Goal Statement

This activity is intended for orthopedists and orthopedic surgeons, rheumatologists, hematology/oncology specialists, diabetologists and endocrinologists, pediatricians, primary care physicians, and other clinicians managing fibrodysplasia ossificans progressiva (FOP).

The goal of this activity is for learners to be more knowledgeable about identifying, diagnosing, and managing FOP.

Upon completion of this activity, participants will:

Have increased knowledge regarding the
- Diagnostic features of FOP 
- Guideline recommendations for patients with FOP 
- Emerging therapies for FOP

Disclosures

Faculty

Geneviève Baujat, MD, MSc

Clinical Geneticist Consultant
Imagine Institute of Necker-Enfants Malades Hospital
Paris, France

Disclosures

Geneviève Baujat, MD, MSc, has the following relevant financial relationships:
Speaker or member of speakers bureau for: Ipsen
Research funding from: Incyte; Ipsen

Patricia L. R. Delai, MD

Professor of Rare Diseases
Dental and Medical School São Leopoldo Mandic
Medical Advisor, Brazilian FOP Association
Member of the International Clinical Council on FOP
São Paulo, Brazil

Disclosures

Patricia L. R. Delai, MD, has the following relevant financial relationships:
Speaker or member of speakers bureau for: Ipsen
Research funding from: Ipsen

Editors

Iwona Misiuta, PhD, MHA

Medical Education Director, Medscape, LLC

Disclosures

Iwona Misiuta, PhD, MHA, has no relevant financial relationships.

Kalanethee Paul-Pletzer, PhD

Medical Education Director, Medscape, LLC

Disclosures

Kalanethee Paul-Pletzer, PhD, has no relevant financial relationships.

Compliance Reviewer

Susan L. Smith, MN, PhD

Associate Director, Accreditation and Compliance, Medscape, LLC

Disclosures

Susan L. Smith, MN, PhD, has no relevant financial relationships.

Peer Reviewer

This activity has been peer reviewed and the reviewer has the following relevant relationships:
Consultant or advisor for: ALife Health
Stock options for: ALife Health

Accreditation Statements

Developed through a collaboration between International Fibrodysplasia Ossificans Progressiva Association (IFOPA) and Medscape Education.

In support of improving patient care, Medscape, LLC is jointly accredited with commendation by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

For Physicians

Medscape, LLC designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credit(s)™ . Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Contact This Provider

For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]

Instructions for Participation and Credit

There are no fees for participating in or receiving credit for this online educational activity. For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.

This activity is designed to be completed within the time designated on the title page; physicians should claim only those credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the activity online during the valid credit period that is noted on the title page. To receive AMA PRA Category 1 Credit™, you must receive a minimum score of 75% on the post-test.

Follow these steps to earn CME/CE credit*:

Read the target audience, learning objectives, and author disclosures.
Study the educational content online or printed out.
Online, choose the best answer to each test question. To receive a certificate, you must receive a passing score as designated at the top of the test. We encourage you to complete the Activity Evaluation to provide feedback for future programming.

You may now view or print the certificate from your CME/CE Tracker. You may print the certificate but you cannot alter it. Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period you can print out the tally as well as the certificates from the CME/CE Tracker.

*The credit that you receive is based on your user profile.

From Medscape Education Orthopaedics

CME

Fibrodysplasia Ossificans Progressiva: Expert Guidance on Diagnosis and Management

Authors: Geneviève Baujat, MD, MSc; Patricia L. R. Delai, MDFaculty and Disclosures

CME Released: 1/4/2023

Valid for credit through: 1/4/2024, 11:59 PM EST

processing....

Contents of This CME Activity

All sections of this activity are required for credit.

Signs and Symptoms of FOP

Familiarize yourself with the signs/symptoms of FOP to reduce the time to diagnosis.
Geneviève Baujat, MD, MSc

Steps to Diagnose FOP

Understand the appropriate diagnostic testing for FOP to prevent misdiagnosis.
Geneviève Baujat, MD, MSc

Medical Management of FOP

Familiarize yourself with the treatment recommendations for FOP.
Patricia L. R. Delai, MD

Complications and Issues to Consider in Managing Patients With FOP

Familiarize yourself with the emergency guidelines for FOP.
Patricia L. R. Delai, MD

Emerging Therapies for FOP

Familiarize yourself on the emerging therapies for FOP.
Geneviève Baujat, MD, MSc

Learning Feedback Questions

Please answer these questions to complement your learning experience.

Page 1 of 8

CME Information Download Slides

Activity Transcript

Print
Like Tweet

Activity Transcript

Disclaimer

The educational activity presented above may involve simulated, case-based scenarios. The patients depicted in these scenarios are fictitious and no association with any actual patient, whether living or deceased, is intended or should be inferred. The material presented here does not necessarily reflect the views of Medscape, LLC, or any individuals or commercial entities that support companies that support educational programming on medscape.org. These materials may include discussion of therapeutic products that have not been approved by the US Food and Drug Administration, off-label uses of approved products, or data that were presented in abstract form. These data should be considered preliminary until published in a peer-reviewed journal. Readers should verify all information and data before treating patients or employing any therapies described in this or any educational activity. A qualified healthcare professional should be consulted before using any therapeutic product discussed herein.

Faculty and Disclosures

Faculty

Geneviève Baujat, MD, MSc

Patricia L. R. Delai, MD

Editors

Iwona Misiuta, PhD, MHA

Kalanethee Paul-Pletzer, PhD

Compliance Reviewer

Susan L. Smith, MN, PhD

Peer Reviewer

CME

Fibrodysplasia Ossificans Progressiva: Expert Guidance on Diagnosis and Management

Credits Available

You Are Eligible For

Target Audience and Goal Statement

Disclosures

Faculty

Geneviève Baujat, MD, MSc

Patricia L. R. Delai, MD

Editors

Iwona Misiuta, PhD, MHA

Kalanethee Paul-Pletzer, PhD

Compliance Reviewer

Susan L. Smith, MN, PhD

Peer Reviewer

Accreditation Statements

For Physicians

Instructions for Participation and Credit

Fibrodysplasia Ossificans Progressiva: Expert Guidance on Diagnosis and Management

Contents of This CME Activity

Signs and Symptoms of FOP

Steps to Diagnose FOP

Medical Management of FOP

Complications and Issues to Consider in Managing Patients With FOP

Emerging Therapies for FOP

Learning Feedback Questions